Skip to main content
Clinical Trials/DRKS00029965
DRKS00029965RecruitingNot Applicable

Implementation of quality indicators from the S3 guideline palliative medicine for patients with non-curable cancer in clinical practice at palliative care units - Quincie

Medizinische Hochschule Hannover0 sites893 target enrollmentStarted: January 20, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
893

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • AP1a: Responsible staff of the palliative care units in the commuting area of the CCC-N.
  • AP1b-1c: Data documented in clinical treatment routine of patients with cancer (ICD10 chapter malignant neoplasms: C00-C97) and a minimum age of 18 years with an inpatient stay of at least three nights at one of the participating palliative care units in the last 12 months prior to data collection.
  • AP2b-2c: Experts for inpatient palliative care, care providers in the cooperating clinics, for example clinical specialists (medical and nursing managers at palliative care units), stakeholders at the meso and macro level of the health care system (e.g. staff from the hospice and palliative care association, from the medical guideline programm oncology and from the coordination centre for palliative medicine of the CCC-N).

Exclusion Criteria

  • AP1a, 2b-2c: No adequate knowledge of the German language.
  • AP1b-1c: Death, transfer or discharge before the end of the third night or/and lack of consent for the scientific use of patient data.

Investigators

Sponsor
Medizinische Hochschule Hannover

Similar Trials